Kidney check: new obesity drug tested in people with kidney problems
NCT ID NCT06352411
First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 23 times
Summary
This study looked at how a new medicine called BI 456906 (for obesity and liver disease) behaves in the blood of people with and without kidney problems. 42 adults received a single injection and were divided into groups based on kidney function. The goal was to see if kidney problems change drug levels, helping doctors decide on proper dosing.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CRS Clinical Research Services Kiel GmbH
Kiel, 24105, Germany
-
CRS Clinical Research Services Mannheim GmbH
Mannheim, 68167, Germany
Conditions
Explore the condition pages connected to this study.